Data as of Q4 2025 (Dec 31, 2025)

HutchMED (China) LIMITED

(HCM)

Financial Statements · SEC EDGAR XBRL

Revenue
$548.5M
-13.0%
Net Income
$456.9M
+1111.0%
EPS
$0.52
+1200.0%
Gross Margin
38.7%
Op. Income
-$39.2M
+10.4%
FCF
-$78.8M
-352.0%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$548.5M
$630.2M
$838.0M
$426.4M
$356.1M
$548.5M
$630.2M
$838.0M
$426.4M
$356.1M
$336.3M
$348.9M
$384.4M
$311.1M
-
$212.2M
$281.3M
$453.6M
$115.3M
-
$148.3M
$212.1M
$302.0M
$386.9M
$299.1M
-$39.2M
-$43.7M
$18.4M
-$407.7M
-$328.3M
-
-
$759K
$652K
$592K
$61.0M
$42.6M
$39.9M
-$2.7M
-$8.7M
$498.7M
-$1.1M
$58.3M
-$410.4M
-$215.7M
$63.6M
$7.2M
$4.5M
-$283K
$11.9M
$456.9M
$37.7M
$100.8M
-$360.8M
-$194.6M
$0.53
$0.04
$0.12
$-0.43
$-0.25
$0.52
$0.04
$0.12
$-0.43
$-0.25
872.9M
872.8M
869.2M
847.1M
792.7M